Proteoglycans, key regulators of cell–matrix dynamics

Matrix Biology - Tập 35 - Trang 1-2 - 2014
Liliana Schaefer1
1Pharmazentrum Frankfurt, Institut für Allgemeine Pharmakologie und Toxikologie, Klinikum der Goethe-Universität Frankfurt am Main, Haus 74, Z. 3.108a, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany

Tài liệu tham khảo

Couchman, 2012, An introduction to proteoglycans and their localization, J. Histochem. Cytochem., 60, 885, 10.1369/0022155412464638 Frey, 2013, Biological interplay between proteoglycans and their innate immune receptors in inflammation, FEBS J., 280, 2165, 10.1111/febs.12145 Iozzo, 1998, Matrix proteoglycans: from molecular design to cellular function, Annu. Rev. Biochem., 67, 609, 10.1146/annurev.biochem.67.1.609 Iozzo, 1996, Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function, FASEB J., 10, 598, 10.1096/fasebj.10.5.8621059 Moreth, 2012, Small leucine-rich proteoglycans orchestrate receptor crosstalk during inflammation, Cell Cycle, 11, 2084, 10.4161/cc.20316 Nastase, 2014, Key roles for the small leucine-rich proteoglycans in renal and pulmonary pathophysiology, Biochim. Biophys. Acta, 10.1016/j.bbagen.2014.01.035 Schaefer, 2011, Small leucine-rich proteoglycans in kidney disease, J. Am. Soc. Nephrol., 22, 1200, 10.1681/ASN.2010050570 Schaefer, 2012, Introduction to proteoglycans: structure, pathobiology and signaling, 135 Schaefer, 2010, Proteoglycans: from structural compounds to signaling molecules, Cell Tissue Res., 339, 237, 10.1007/s00441-009-0821-y